Actinic Keratosis Medications

5%

designed to target viral or abnormal cell lesions and to alleviate site-specific skin conditions.

1 · 5%

utilized to target actinic keratosis and intended to support the reduction of cancerous skin cell proliferation.

1 · 5%

This topical treatment is indicated to target precancerous skin lesions and certain carcinomas, formulated to alleviate damaged cell growth.

5%

Indicated to target actinic keratosis and genital warts and to support the immune response to eradicate abnormal skin cells.